OGN NYSE
Organon & Co.
1W: -0.1%
1M: +0.1%
3M: +1.6%
YTD: +90.4%
1Y: +50.4%
3Y: -3.4%
5Y: -52.4%
$13.75
+0.01 (+0.07%)
Pre-Market: $13.77 (+0.02, +0.15%)
Weekly Expected Move ±0.5%
$14
$14
$14
$14
$14
Credit Risk of going bust: higher than 87% of companies Debt: 70.3% of company value Bonds: $567.6M held by 309 funds, 116 bp over Treasuries → details ▾
Of US companies ranked in the second-riskiest tenth, about 1 in 87 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $2.24 (down 84%), Organon & Co. would be worth roughly what it owes.
Total debt $8.55B against a stock market value of $3.61B.
Distance to default 1.98 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $4.31B (short-term plus half of long-term), stock volatility 62.2%; Altman Z 1.25. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $2.24 (down 84%), Organon & Co. would be worth roughly what it owes.
Total debt $8.55B against a stock market value of $3.61B.
Distance to default 1.98 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $4.31B (short-term plus half of long-term), stock volatility 62.2%; Altman Z 1.25. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.00
Neutral
0 bullish
2 neutral
0 bearish
Articles (7d)
2
Daily Sentiment (7 Days)
Articles (100)
Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It
Head-To-Head Comparison: GSK (NYSE:GSK) and Organon & Co. (NYSE:OGN)
Organon & Co. (NYSE:OGN) & Xeris Biopharma (NASDAQ:XERS) Critical Comparison
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know
Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock
Is Trending Stock Organon & Co. (OGN) a Buy Now?
Financial Analysis: Organon & Co. (NYSE:OGN) versus Spero Therapeutics (NASDAQ:SPRO)
VIRGINIA RETIREMENT SYSTEMS ET Al Makes New $770,000 Investment in Organon & Co. $OGN
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
Bank of America Corp DE Has $4.42 Million Stock Position in Organon & Co. $OGN
Organon & Co. (NYSE:OGN) Sets New 52-Week High – Still a Buy?
Organon & Co. (NYSE:OGN) Reaches New 12-Month High – Still a Buy?
Organon & Co. $OGN Shares Purchased by California State Teachers Retirement System
Analyzing Finch Therapeutics Group (NASDAQ:FNCH) and Organon & Co. (NYSE:OGN)
Organon & Co. (NYSE:OGN) Receives $11.40 Consensus Price Target from Analysts
Compared to Estimates, Organon (OGN) Q2 Earnings: A Look at Key Metrics
Organon (OGN) Lags Q2 Earnings Estimates
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
Catalyst watch: Farnborough Air Show, Tesla earnings, AMD AI event, and Samsung reveals
Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know
Can Organon & Co. (OGN)’s MIUDELLA Launch Become a Major Driver in Women’s Health Markets?
Record-setting healthcare M&A activity to extend through H2: PwC
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
Halper Sadeh LLC is Investigating Whether LPRO, NUVL, OGN, SUNE are Obtaining Fair Deals for their Shareholders
Organon Wins FDA Nod to Expand TOFIDENCE Use in Severe CRS & COVID-19
Halper Sadeh LLC is Investigating Whether NUVL, SUNE, OGN, TMHC are Obtaining Fair Deals for their Shareholders
Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
Insider trades: Intel, Bank of America, and Pinterest among notable names
Halper Sadeh LLC is Investigating Whether HLX, OGN, XOMA, RMAX are Obtaining Fair Deals for their Shareholders
Halper Sadeh LLC is Investigating Whether SLNO, OGN, RMAX, XOMA are Obtaining Fair Deals for their Shareholders
Halper Sadeh LLC is Investigating Whether MKC, LEG, OGN, KW are Obtaining Fair Deals for their Shareholders
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX), Soleno Therapeutics, Inc. (Nasdaq – SLNO)
MaxLinear is the best performing mid cap stock
Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It
Organon & Co is the best performing healthcare stock in April
Key deals this week: Organon, ARC Resources, Nebius, Eli Lilly and more
Trending stocks this week as Big Tech earnings lift markets amid Fed pause
Deal Dispatch: Sirius XM Mulls Purchase Of iHeartMedia, Uber Buys FlyTaxi, Wren Kitchens Bankruptcy
Organon declares $0.02 dividend
Organon (OGN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Organon (OGN) Q1 Earnings and Revenues Miss Estimates
Company News for Apr 28, 2026
This Old Dominion Freight Line Analyst Is No Longer Bearish; Here Are Top 3 Upgrades For Tuesday
Organon & Co. (OGN) Soars to 52-Week High on $11.75-Billion Sun Merger
Halper Sadeh LLC is Investigating Whether OGN, XOMA, RMAX, SLNO are Obtaining Fair Deals for their Shareholders
Stock Market Today, April 27: Organon Shares Surge After Sun Pharma Agrees to Acquire Company in All Cash Deal
Organon Shares Rally 16% in Premarket as Sun Pharma Announces Buyout
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX), Soleno Therapeutics, Inc. (Nasdaq – SLNO)
Johnson Fistel Investigates Potential Breaches of Fiduciary Duty in Connection with the Proposed Acquisition of Organon by Sun Pharmaceutical
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Organon & Co. (NYSE: OGN)
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Organon & Co. (NYSE: OGN)
Organon (OGN) Soars 30.9%: Is Further Upside Left in the Stock?
12 Health Care Stocks Moving In Monday's Pre-Market Session
Why Is Organon Stock Skyrocketing Monday?
Biggest stock movers Monday: OGN, QCOM, and more
Stock Market Today: Dow Jones, S&P 500 Futures Fall As Trump Halts Iran Talks—Organon, SAP, Cheetah Net Supply Chain Service In Focus
Organon To Be Acquired By Sun Pharma In $11.75B Deal, OGN Stock Spikes Nearly 17% On Robinhood 24-Hour Market
Sun Pharma shares jump over 4% after firm announces $12-billion Organon acquisition
Sun Pharma to buy Organon in $11.75B deal, expanding global reach
Organon & Co. (NYSE:OGN) Shares Gap Up – Still a Buy?
Organon: What The Buyout Rumors Mean For The Stock (NYSE:OGN) - Seeking Alpha
Why is OGN stock rising in pre-market today? - MSN
OGN stock surges 20% pre-market, on track to break 200-DMA – why this buyout report has caught investor attention - MSN
Biggest stock movers Monday: OGN, CRWD and more - MSN
Organon (OGN) Takeover Bid Climbs to $13B, Shares Soar 30.9%
Organon (OGN) Takeover Bid Climbs to $13B, Shares Soar 30.9% - Yahoo Finance
Biggest stock movers Friday: OGN, SLP, TGLS, and more - MSN
Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma - Barron's
Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma
These Stocks Are Today’s Movers: Intel, Nvidia, AMD, Organon, Charter, X-Energy, Newmont, Meta, and More
Sector Update: Health Care Stocks Fall Late Afternoon
Sector Update: Health Care Stocks Decline in Afternoon Trading
Organon shares jump on renewed takeover chatter tied to a reported Sun Pharma bid | OGN Stock News - Quiver Quantitative
Nasdaq 100 Marks Fresh Records, Intel Jumps 23% On AI Chip Mania: Stock Market Today
12 Health Care Stocks Moving In Friday's Intraday Session
Organon & Co. (NYSE:OGN) Shares Gap Up - Should You Buy? - MarketBeat
Sensient Technologies, Chemed, AMD, Arm And Other Big Stocks Moving Higher On Friday
Organon Stock Jumps as Sun Pharma’s Reported $13 Billion Bid Puts OGN in Takeover Spotlight - TechStock²
Nasdaq Composite Rises on Cautious Optimism on Tech Tailwinds but Iran Tensions Loom
Evercore ISI Says Sun Pharma Deal Talk for Organon & Co. (OGN) Lacks Confirmation, Remains Speculative
Evercore ISI Says Sun Pharma Deal Talk for Organon & Co. (OGN) Lacks Confirmation, Remains Speculative
Organon Stock (OGN) Surges on Reports of a $13B Bid - TipRanks
Exchange-Traded Funds Rise, Equity Futures Mixed Pre-Bell as Traders Assess Tech Earnings Amid Global Uncertainty
Organon stock climbs amid buyout rumors (OGN:NYSE) - Seeking Alpha
Organon climbs amid reports of $13B buyout bid from Sun Pharma
12 Health Care Stocks Moving In Friday's Pre-Market Session
Brokerages Set Organon & Co. (NYSE:OGN) PT at $8.50
Organon (OGN) Dips More Than Broader Market: What You Should Know
Organon (OGN) Dips More Than Broader Market: What You Should Know - Yahoo Finance
Organon (OGN) Dips More Than Broader Market: What You Should Know
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Why Organon (OGN) Drew Buyout Buzz After a Sharp Repricing - Yahoo Finance
Why Organon (OGN) Drew Buyout Buzz After a Sharp Repricing
Apellis Pharmaceuticals is the most overbought healthcare stock as Q1 earnings roll on
Assessing Organon (OGN) Valuation After VTAMA’s Key Pediatric Guideline Endorsement